Toxicidad pulmonar asociada a inmunoterapia con Nivolumab : presentación de un caso.
Toxicidad pulmonar asociada a inmunoterapia con Nivolumab : presentación de un caso.
Issue
Section
Pósters otros
How to Cite
Toxicidad pulmonar asociada a inmunoterapia con Nivolumab : presentación de un caso.
rev. colomb. neumol. [Internet]. 2020 Dec. 3 [cited 2024 Nov. 19];31(2). Disponible en: https://doi.org/10.30789/rcneumologia.v31.n2.2019.480
Dimensions
license
Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.
Show authors biography
Article visits 536 | PDF visits 384
Downloads
Download data is not yet available.
- Nishino M, Ramaiya NH, Awad MM, Sholl LM4, Maattala JA, Taibi M, Hatabu H, Ott PA, Armand PF HF. PD-1 inhibitor-related pneumonitis in advanced cancer. Clin Cancer Res [Internet]. 2016;22(24):6051–60. Available from : https://www.ncbi.nlm.nih.gov/pubmed/27535979
- Nishino M, Giobb ie-Hurder A, Hatabu H, Ramaiya NH, Hodi FS. Incidence of programmed cell death 1 inhibitorrelated pneumonitis in patients with advanced cancer a systematic review and meta-analysis. JAMA Oncol . 2016;2(12):1607–16.
- Nishijima TF, Shachar SS, Nyrop KA, Muss HB. Safety and Tolerability of PD-1/PD-L1 Inhibitors Compared with Chemotherapyin Patients with Advanced Cancer:AMeta-Analysis.Oncologist.2017;22(4):470–9.
- Khunger M, Rakshit S, Pasupuleti V, Hernandez AV., Mazzone P, Stevenson J,et al. Incidence of programmed cel l death 1 inhibitor-related pneumonitis in patients with advanced cancer a systematic review and meta-analysis . Oncologist [Internet].2017;157631(4):709–17.Available from:http://dx.doi.org/10.1016/j.chest.2017.04.177
- Naidoo J, Wang X, Woo K M, Iyriboz T, HalpennyD, Cunningham J,et al. Pneumonitis in patients treated with antiprogrammed death-1/programmed death ligand 1 therapy. JClin Oncol.2017;35(7):709–17.
- Rashdan S, Minna JD, Gerber DE. Diagnosis and management of pulmonary toxicity associated with cancer immunotherapy.The Lancet RespiratoryMedicine.2018.
Information
Journal history
Keywords
QR code
Funding
Support + Info: Here
Directories and indexes
Google Scholar profile
Most read in the last 30 days
